Cardiovascular prevention and international health: time for action

Abegunde DO Mathers CD Adam T Ortegon M Strong K . The burden and cost of chronic disease in low-income and middle-income countries. Lancet 2007; 370: 1929–1938.

Beaglehole R Horton R . Chronic disease: global action must match global evidence. Lancet 2011; 376: 1619–1621.

Omran AR . The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 1971; 49: 509–538.

Yusuf S Reddy S Ôunpuu S Anand S . Global burden of cardiovascular disease. Part I: General considerations, the epidemiologic transition, risk factors and impact of urbanisation. Circulation 2001; 104: 2746–2753.

UN. Millennium summit goals 2000; New York: United Nations.

Bill and Melinda Gates Foundation. Global Health Strategy Overview. 2010, http://www.gatesfoundation.org/global-health/Documents/global-health-strategy-overview.pdf (accessed 16 February 2011).

Sen K Bonita R . Global health status: two steps forward, one step back. Lancet 2000; 356: 577–582.

Strong K Mathers C Leeder S Beaglehole R . Preventing chronic diseases: how many lives can we save? Lancet 2005; 366: 1578–1582.

Horton R . The neglected epidemic of chronic disease. Lancet 2005; 366: 1514–1514.

Horton R . Chronic disease: the case for urgent global action. Lancet 2007; 370: 1929–1938.

WHO. Preventing chronic disease: a vital investment: WHO global report. Geneva: World Health Organization, 2005.

Murray CJL Lopez AD . Mortality by cause of eight regions in the world: Global Burden of Disease Study. Lancet 1997; 349: 1269–1276.

WHO. Fact sheet – The top ten causes of death. http://www.who.int/mediacentre/factsheets/fs310_2008.pdf (accessed 17 February 2011).

Fuster V Voute J Hunn M Smith SC Jr . Low priority of cardiovascular and chronic disease on the global health agenda – a cause for concern. Circulation 2007; 116: 1966–1970.

Leeder S Raymond S Greenberg H Liu H . A race against time: the challenge of cardiovascular disease in developing economies 2004; New York: The Earth Institute, Columbia University.

Alwan A MacLean DR Riley LM Tursan d’Espaignet E Mathers CD Stevens GA . Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet 2010; 376: 1861–1868.

Lim SS Gaziano TA Gakidou E Reddy KS Farzadfar F Lozano R . Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007; 370: 2054–2062.

Asria P Chisholm D Mathers C Ezzati M Beaglehole R . Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007; 370: 2054–2062.